Publication Date
1-1-2024
Content Type
Article
PubMed ID:
Citation
Hanna, G. J., Villa, A., Nandi, S. P., Shi, R., ONeill, A., Liu, M., Quinn, C. T., Treister, N. S., Sroussi, H. Y., Vacharotayangul, P., Goguen, L. A., Annino, D. J., Jr, Rettig, E. M., Jo, V. Y., Wong, K. S., Lizotte, P., Paweletz, C. P., Uppaluri, R., Haddad, R. I., Cohen, E. E. W., … Woo, S. B. (2024). Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA oncology, 10(1), 32–41. https://doi.org/10.1001/jamaoncol.2023.4853
Comments
This is an open access article distributed under the terms of the CC-BY-NC-ND license, which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.